Sector Update : NCR hospitals on adrenalin By Elara Capital
Follow us Now on Telegram ! Get daily 10 - 12 important updates on Business, Finance and Investment. Join our Telegram Channel
https://t.me/InvestmentGuruIndiacom
Download Telegram App before Joining the Channel
NCR hospitals on adrenalin
Hospitals at full occupancy; managements remain optimistic
Our site visits of six flagship hospital facilities in the NCR (belonging to Fortis Healthcare (FORH IN), Max Healthcare (MAXHEALTH IN), Indraprastha Medical Corporation (IMC IN), Yatharth Hospital [YATHARTH IN], Global Health (MEDANTA IN) and Artemis Health (ARTMSL IN)) reveal continued strong demand environment. All these facilities were crowded with patients and almost all beds were occupied. The management personnel, across levels, were very bullish on the demand environment and exuded confidence that the region can absorb any sort of increase in bed capacity.
Pushing ahead with major expansion plans
Top management of respective companies continue to share a bullish outlook. They have major expansion plans in NCR as well as other regions. While MAXHEALTH and MEDANTA reiterated their plans with specifics, others talked about significant expansion plans in terms of bed capacity. None seemed concerned about filling up new bed capacity – they sound confident about a rapid pickup in new beds occupancy and break-even of new facilities in a year’s time.
No envisioning of draconian price regulation
While management remain concerned about the recent Supreme Court directive on pricing regulation of healthcare services, none expect the government to implement a draconian price control regime that can kill the private healthcare industry. At the same time, they expect some sort of price regulation to come into effect. All say the current social responsibility commitments are being fully met in terms of reserving beds for the economically weaker sections (EWS). Even the currently reserved beds are not fully occupied.
Our view: retain our cautious stance on high valuation
Although we do not see a major deterioration in strong momentum, we see softening of growth and margin in the next 2-4 quarters. In our view, all-time high valuations do not price this in. Hence, we remain cautious as companies are likely to disappoint strong growth expectations that we believe are built into the stock price. Among our coverage universe, we reiterate Reduce on Apollo Hospitals (APHS IN) and Accumulate on Fortis Healthcare (FORH IN). We retain Buy on Shalby (SHALBY IN), given relatively reasonable valuation
Please refer disclaimer at Report
SEBI Registration number is INH000000933
